Product Images Progesterone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Progesterone NDC 71205-293 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structural Formula - pro0g 0003 01

Table 1 - pro0g 0003 02

Table 2 - pro0g 0003 03

This appears to be a table showing pharmacokinetic parameters for Estradiol, Estrone and Equilin following co-administration of Conjugated Estrogens and Progesterone Capsules for 12 days to postmenopausal women. The table shows the drug concentration at different time points, AUCs, and cumulative AUC for the drugs.*

Table 3 - pro0g 0003 04

The text appears to be a combination of a report and medical prescription notes. It discusses a study on endometrial hyperplasia in women receiving three years of treatment. The treatment group is mentioned with drugs administered that include estrogen and progesterone. The number of patients observed during the study is mentioned. There are also some technical terms related to therapy and endometrial hyperplasia.*

Figure 1 - pro0g 0003 05

The text appears to be a figure or graph with a title "Time on Ryperpas Treatment". It shows the time period of up to 36 months of treatment. The y-axis is labelled as "n=total number of patients left at each time interval" while the x-axis is labelled as "Time (months) on medication". The data is presented in the form of a bar graph with different bars representing the number of patients remaining on medication at different time intervals. However, without visual context, it is hard to make any inferences or conclusions from this data. Therefore, the description of the data is limited to what has already been stated.*

Table 4 - pro0g 0003 06

Table 5 - pro0g 0003 07

Table 6 - pro0g 0003 08

This is a report on the adverse reactions reported in a 3-year long placebo-controlled trial of Progesterone Capsules in combination with Conjugated Estrogens in postmenopausal women. The adverse reactions reported include headache, breast tenderness, joint pain, depression, hot flashes, urinary problems, chest pain, diarrhea, constipation, nausea/vomiting, fatigue, swelling of hands and feet, vaginal discharge and dryness. The incidence of breast carcinoma, breast excisional biopsy, cholecystectomy is also recorded.*

Table 7 - pro0g 0003 09

This appears to be a table describing the adverse reactions reported by patients using Progesterone Capsules at 400mg/day in a placebo-controlled trial with estrogen-primed postmenopausal women. The table lists several adverse reactions along with the number of patients who experienced the reaction and the percentage of patients. The adverse reactions include headache, bloating, cramping, diarrhea, back pain, muscle pain, and coughing.*

71205-293-30 - pro0g 0004 11

Progesterone 200mg capsules are available in a pack of 30 and are manufactured by SNEMASTER. Each oval, beige-capsule branded with "AK2 430" imprint contains 200mg of micronized USP progesterone. The capsules are RX only and should not be used if allergic to peanuts. These capsules should be stored at 25°C (77°F) and kept out of the reach of children.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.